Skip to menu Skip to content Skip to footer
Dr Sam Hollingworth
Dr

Sam Hollingworth

Email: 

Overview

Background

I am an academic and consultant working in global health with a focus on health technology assessment (HTA), health systems and services research, and the use of medicines in populations. I have a particular interest in the use of data and research for evidence-informed decision making and implementation science in the context of low and middle income countries, especially in sub-Saharan Africa. I have worked on international health projects in Indonesia and am currently working on several projects in HTA and medicines use in Ghana and sub-Saharan Africa. I work with an extensive network of clinicians and health professionals to investigate the use of medicines and adverse effects in general practice, cancer, psychiatry, neurology, and internal medicine. I have honorary or visiting appointments at the University of Queensland (UQ, Brisbane, Australia), Imperial College London (UK, International Decision Support Initiative) and Kwame Nkrumah University of Science and Technology (KNUST, Kumasi, Ghana). I have a BSc(Hons) and MPH from UQ and a PhD from Monash University. I have lived or worked in Australia (Brisbane, Melbourne), Canada (Toronto), Indonesia (Yogyakarta), UK (London), and Ghana (Accra, Kumasi). I worked as a consultant in HTA in Australia for many years evaluating submissions to subsidise medicines on the Pharmaceutical Benefits Scheme (PBS). I am an experienced teacher having coordinated courses, lectured, and tutored in undergraduate and postgraduate programs. I was a Foundation Coordinator in the UQ Master of Pharmaceutical Industry Practice (from 2019). I am an advisor on diverse PhD and student research projects.

Availability

Dr Sam Hollingworth is:
Not available for supervision
Media expert

Qualifications

  • Bachelor (Honours) of Science (Advanced), The University of Queensland
  • Doctor of Philosophy, Monash University
  • Masters (Coursework) of Public Health, The University of Queensland

Research interests

  • Health technology assessment (HTA) and decision-making

    Working with partners in low and middle income countries to manage and allocate their finite resources to ensure their healthcare systems meet the need for universal healthcare coverage efficiently and equitably

  • Economic evaluations within health care and evidence-based practice

    Critically appraising the quality of evidence and ‘value for money’ of medicines and health services

  • Use of medicines in populations (pharmacoepidemiology)

    Exploring the use of medicines and their side effects using routinely collected data and describing the ‘real world’ effectiveness of medicines (e.g. in cancer)

  • Health systems, services, and medicines in non-communicable diseases

    Describing the use of medicines and other health services to treat non-communicable diseases (NCDs) with a focus on low and middle income countries

Works

Search Professor Sam Hollingworth’s works on UQ eSpace

212 works between 1988 and 2024

41 - 60 of 212 works

2021

Journal Article

Metformin reduces 12-month change in body weight among people newly commenced on clozapine: a retrospective naturalistic cohort study

Spokes, Jessica, Hollingworth, Samantha, Winckel, Karl, Kisely, Steve, Baker, Andrea, Cosgrove, Peter and Siskind, Dan (2021). Metformin reduces 12-month change in body weight among people newly commenced on clozapine: a retrospective naturalistic cohort study. Therapeutic Advances in Psychopharmacology, 11, 1-7. doi: 10.1177/20451253211000609

Metformin reduces 12-month change in body weight among people newly commenced on clozapine: a retrospective naturalistic cohort study

2021

Journal Article

Questioning the accuracy and interpretation of dispensed patterns of dental emergency medicines

Teoh, Leanne, Moses, Geraldine, Hollingworth, Samantha and McCullough, Michael J. (2021). Questioning the accuracy and interpretation of dispensed patterns of dental emergency medicines. International Dental Journal, 71 (4), 281-282. doi: 10.1016/j.identj.2020.12.011

Questioning the accuracy and interpretation of dispensed patterns of dental emergency medicines

2020

Journal Article

Antidepressant use in Australia and Sweden – A cross‐country comparison

Eek, Emma, Driel, Mieke, Falk, Magnus, Hollingworth, Samantha A. and Merlo, Gregory (2020). Antidepressant use in Australia and Sweden – A cross‐country comparison. Pharmacoepidemiology and Drug Safety, 30 (4) pds.5158, 1-9. doi: 10.1002/pds.5158

Antidepressant use in Australia and Sweden – A cross‐country comparison

2020

Journal Article

Pharmaceutical opioids utilisation by dose, formulation, and socioeconomic status in Queensland, Australia: a population study over 22 years

Adewumi, Adeleke D., Maravilla, Joemer C., Alati, Rosa, Hollingworth, Samantha A., Hu, Xuelei, Loveday, Bill and Connor, Jason P. (2020). Pharmaceutical opioids utilisation by dose, formulation, and socioeconomic status in Queensland, Australia: a population study over 22 years. International Journal of Clinical Pharmacy, 43 (2), 328-339. doi: 10.1007/s11096-020-01155-5

Pharmaceutical opioids utilisation by dose, formulation, and socioeconomic status in Queensland, Australia: a population study over 22 years

2020

Journal Article

Time to rethink our approach to the Pharmaceutical Benefits Scheme (PBS) listing of medicines: the case of pregabalin

Winckel, Karl, Daglish, Mark, Pache, David and Hollingworth, Samantha A. (2020). Time to rethink our approach to the Pharmaceutical Benefits Scheme (PBS) listing of medicines: the case of pregabalin. Australian Health Review, 45 (2), 261-262. doi: 10.1071/ah20060

Time to rethink our approach to the Pharmaceutical Benefits Scheme (PBS) listing of medicines: the case of pregabalin

2020

Journal Article

Multiple opioid prescribers: a genuine quest for treatment rather than aberrant behaviour. A two-decade population-based study

Adewumi, Adeleke D., Maravilla, Joemer C., Alati, Rosa, Hollingworth, Samantha A., Hu, Xuelei, Loveday, Bill and Connor, Jason P. (2020). Multiple opioid prescribers: a genuine quest for treatment rather than aberrant behaviour. A two-decade population-based study. Addictive Behaviors, 108 106458, 1-8. doi: 10.1016/j.addbeh.2020.106458

Multiple opioid prescribers: a genuine quest for treatment rather than aberrant behaviour. A two-decade population-based study

2020

Journal Article

Withdrawal and misuse concerns of consumers regarding opioid analgesic and anxiolytic, hypnotic and sedative medicines

McGuire, Treasure M., Sidhu, Kudrat, van Driel, Mieke L. and Hollingworth, Samantha A. (2020). Withdrawal and misuse concerns of consumers regarding opioid analgesic and anxiolytic, hypnotic and sedative medicines. Substance Use and Misuse, 55 (12), 1-13. doi: 10.1080/10826084.2020.1784948

Withdrawal and misuse concerns of consumers regarding opioid analgesic and anxiolytic, hypnotic and sedative medicines

2020

Journal Article

Real-world questions and concerns about disease-modifying antirheumatic drugs (DMARDs): a retrospective analysis of questions to a medicine call center

EL Masri, Hiba, Hollingworth, Samantha A., van Driel, Mieke, Benham, Helen and McGuire, Treasure M. (2020). Real-world questions and concerns about disease-modifying antirheumatic drugs (DMARDs): a retrospective analysis of questions to a medicine call center. BMC Rheumatology, 4 (1) 27, 27. doi: 10.1186/s41927-020-00126-7

Real-world questions and concerns about disease-modifying antirheumatic drugs (DMARDs): a retrospective analysis of questions to a medicine call center

2020

Journal Article

Duration of opioid use and association with socioeconomic status, daily dose and formulation: a two-decade population study in Queensland, Australia

Adewumi, Adeleke D., Maravilla, Joemer C., Alati, Rosa, Hollingworth, Samantha A., Hu, Xuelei, Loveday, Bill and Connor, Jason P. (2020). Duration of opioid use and association with socioeconomic status, daily dose and formulation: a two-decade population study in Queensland, Australia. International Journal of Clinical Pharmacy, 43 (2), 340-350. doi: 10.1007/s11096-020-01079-0

Duration of opioid use and association with socioeconomic status, daily dose and formulation: a two-decade population study in Queensland, Australia

2020

Journal Article

Dental opioid prescribing rates after the up-scheduling of codeine in Australia

Teoh, L., Hollingworth, S., Marino, R. and McCullough, M. J. (2020). Dental opioid prescribing rates after the up-scheduling of codeine in Australia. Scientific Reports, 10 (1) 8463, 8463. doi: 10.1038/s41598-020-65390-6

Dental opioid prescribing rates after the up-scheduling of codeine in Australia

2020

Journal Article

Bortezomib use and outcomes for the treatment of multiple myeloma

Loke, Crystal, Mollee, Peter, McPherson, Ian, Walpole, Euan, Yue, Mimi, Mutsando, Howard, Wong, Phillip, Weston, Helen, Tomlinson, Ross and Hollingworth, Samantha (2020). Bortezomib use and outcomes for the treatment of multiple myeloma. Internal Medicine Journal, 50 (9) imj.14886, 1059-1066. doi: 10.1111/imj.14886

Bortezomib use and outcomes for the treatment of multiple myeloma

2020

Other Outputs

iDSI HTA survey SSA Data sharing

Hollingworth, Samantha, Ruiz, Francis, Gad, Mohamed and Chalkidou, Kalipso (2020). iDSI HTA survey SSA Data sharing. The University of Queensland. (Dataset) doi: 10.14264/uql.2020.178

iDSI HTA survey SSA Data sharing

2019

Journal Article

Availability, price, and affordability of essential medicines to manage noncommunicable diseases: a national survey from Nepal

Khanal, Saval, Veerman, Lennert, Ewen, Margaret, Nissen, Lisa and Hollingworth, Samantha (2019). Availability, price, and affordability of essential medicines to manage noncommunicable diseases: a national survey from Nepal. Inquiry, 56, 004695801988757. doi: 10.1177/0046958019887572

Availability, price, and affordability of essential medicines to manage noncommunicable diseases: a national survey from Nepal

2019

Journal Article

Consumption of medicines used for gastric acid-related disorders in Australia and South Korea: a cross-country comparison

Yu, Su-Yeon, Lee, Boram, McGuire, Treasure M., Lee, Hye-Jae and Hollingworth, Samantha A. (2019). Consumption of medicines used for gastric acid-related disorders in Australia and South Korea: a cross-country comparison. European Journal of Clinical Pharmacology, 76 (4), 547-555. doi: 10.1007/s00228-019-02798-8

Consumption of medicines used for gastric acid-related disorders in Australia and South Korea: a cross-country comparison

2019

Conference Publication

Real-world survival of advanced melanoma patients treated with immunotherapy and targeted therapy

Yu, Su-Yeon, McKavanagh, Dan, McPherson, Ian, Walpole, Euan, Hollingworth, Samantha and Atkinson, Victoria (2019). Real-world survival of advanced melanoma patients treated with immunotherapy and targeted therapy. HOBOKEN: WILEY.

Real-world survival of advanced melanoma patients treated with immunotherapy and targeted therapy

2019

Journal Article

Antifungal agents for invasive candidiasis in non-neutropenic critically-ill adults: what do the guidelines recommend?

Wang, Yan, McGuire, Treasure M., Hollingworth, Samantha A., Dong, Yalin and Van Driel, Mieke L. (2019). Antifungal agents for invasive candidiasis in non-neutropenic critically-ill adults: what do the guidelines recommend?. International Journal of Infectious Diseases, 89, 137-145. doi: 10.1016/j.ijid.2019.10.016

Antifungal agents for invasive candidiasis in non-neutropenic critically-ill adults: what do the guidelines recommend?

2019

Journal Article

Strategies to counter antipsychotic-associated weight gain in patients with schizophrenia

Marteene, Wade, Winckel, Karl, Hollingworth, Sam, Kisely, Steve, Gallagher, Erin, Hahn, Margaret, Ebdrup, Bjørn H, Firth, Joseph and Siskind, Dan (2019). Strategies to counter antipsychotic-associated weight gain in patients with schizophrenia. Expert Opinion on Drug Safety, 18 (12), 1-12. doi: 10.1080/14740338.2019.1674809

Strategies to counter antipsychotic-associated weight gain in patients with schizophrenia

2019

Journal Article

Longitudinal impact of the Women’s Health Initiative study on hormone therapy use in Australia

Natari, R. B., McGuire, T. M., Baker, P. J., Clavarino, A. M., Dingle, K. D. and Hollingworth, S. A. (2019). Longitudinal impact of the Women’s Health Initiative study on hormone therapy use in Australia. Climacteric, 22 (5), 489-497. doi: 10.1080/13697137.2019.1593357

Longitudinal impact of the Women’s Health Initiative study on hormone therapy use in Australia

2019

Journal Article

Why aren't Australian pharmacists supplying naloxone? Findings from a qualitative study

Olsen, Anna, Lawton, Belinda, Dwyer, Robyn, Taing, Meng-Wong, Chun, Ka Lai Joyce, Hollingworth, Samantha and Nielsen, Suzanne (2019). Why aren't Australian pharmacists supplying naloxone? Findings from a qualitative study. International Journal of Drug Policy, 69, 46-52. doi: 10.1016/j.drugpo.2019.03.020

Why aren't Australian pharmacists supplying naloxone? Findings from a qualitative study

2019

Journal Article

Response to Comment on Johnson et al. Cost-effectiveness analysis of routine screening using massively parallel sequencing for maturity-onset diabetes of the young in a pediatric diabetes cohort: reduced health system costs and improved patient quality of life. Diabetes Care 2019;42:69–76

Johnson, Stephanie R., Carter, Hannah E., Leo, Paul, Hollingworth, Samantha A., Davis, Elizabeth A., Jones, Timothy W., Conwell, Louise S., Harris, Mark, Brown, Matthew A., Graves, Nicholas and Duncan, Emma L. (2019). Response to Comment on Johnson et al. Cost-effectiveness analysis of routine screening using massively parallel sequencing for maturity-onset diabetes of the young in a pediatric diabetes cohort: reduced health system costs and improved patient quality of life. Diabetes Care 2019;42:69–76. Diabetes Care, 42 (5), e79-e80. doi: 10.2337/dci19-0010

Response to Comment on Johnson et al. Cost-effectiveness analysis of routine screening using massively parallel sequencing for maturity-onset diabetes of the young in a pediatric diabetes cohort: reduced health system costs and improved patient quality of life. Diabetes Care 2019;42:69–76

Funding

Past funding

  • 2021 - 2024
    Opioids and other prescription medicines use in people presenting to Queensland emergency departments for acute minor (non-admitted) Road Traffic Crash injury: a one year community follow-up study usi
    Metro South Hospital and Health Service
    Open grant
  • 2013 - 2014
    Utilisation review of Ezetimibe
    Department of Health and Ageing
    Open grant
  • 2012 - 2013
    Prescription opioid users in Australia- just who are they?
    UQ New Staff Research Start-Up Fund
    Open grant
  • 2010 - 2018
    NHMRC CRE: Improving quality and safety of health care delivery at the interface between primary and acute care sectors
    NHMRC Centres of Research Excellence
    Open grant

Supervision

Availability

Dr Sam Hollingworth is:
Not available for supervision

Supervision history

Current supervision

Completed supervision

Media

Enquiries

Contact Dr Sam Hollingworth directly for media enquiries about:

  • health services research
  • medicine use in populations
  • pharmacoepidemiology

Need help?

For help with finding experts, story ideas and media enquiries, contact our Media team:

communications@uq.edu.au